Cindy Tahl's most recent trade in Fate Therapeutics Inc was a trade of 25,590 Common Stock done at an average price of $1.9 . Disclosure was reported to the exchange on May 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fate Therapeutics Inc | Cindy R. Tahl | See Remarks | Sale of securities on an exchange or to another person at price $ 1.88 per share. | 20 May 2026 | 25,590 | 628,155 (0%) | 0% | 1.9 | 48,084 | Common Stock |
| Fate Therapeutics Inc | Cindy R. Tahl | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. | 06 May 2026 | 122,220 | 609,301 (0%) | 0% | 1.3 | 161,330 | Common Stock |
| Fate Therapeutics Inc | Cindy R. Tahl | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 122,220 | 152,780 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy R. Tahl | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 44,444 | 355,556 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy R. Tahl | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 06 May 2026 | 44,444 | 653,745 (0%) | 0% | 1.0 | 46,666 | Common Stock |
| Fate Therapeutics Inc | Cindy R. Tahl | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy R. Tahl | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 100,000 | 487,081 (0%) | 0% | 0 | Common Stock | |
| Fate Therapeutics Inc | Cindy R. Tahl | See Remarks | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 09 Jan 2026 | 10,589 | 387,081 (0%) | 0% | 1.1 | 11,275 | Common Stock |
| Fate Therapeutics Inc | Cindy R. Tahl | See Remarks | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 04 Aug 2025 | 9,037 | 397,670 (0%) | 0% | 1.1 | 9,573 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl R. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy Tahl R. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 70,000 | 406,707 (0%) | 0% | 0 | Common Stock | |
| Fate Therapeutics Inc | Cindy Tahl R. | See Remarks | Sale of securities on an exchange or to another person at price $ 1.55 per share. | 10 Jan 2025 | 5,654 | 336,707 (0%) | 0% | 1.6 | 8,764 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 200,000 | 342,361 (0%) | 0% | 0 | Common Stock | |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 425,000 | 425,000 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 4.37 per share. | 09 Jan 2024 | 10,874 | 142,361 (0%) | 0% | 4.4 | 47,519 | Common Stock |
| Fate Therapeutics Inc | Tahl Cindy | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 2.40 per share. | 09 Nov 2023 | 24,363 | 153,235 (0%) | 0% | 2.4 | 58,471 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 425,000 | 425,000 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 5.24 per share. | 10 Jan 2023 | 11,553 | 177,598 (0%) | 0% | 5.2 | 60,538 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 22.96 per share. | 01 Jun 2022 | 25,000 | 189,151 (0%) | 0% | 23.0 | 574,000 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 01 Jun 2022 | 25,000 | 214,151 (0%) | 0% | 6.6 | 163,750 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 25,000 | 54,210 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy Tahl | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 53,058 | 53,058 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy Tahl | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 33,302 | 189,151 (0%) | 0% | 0 | Common Stock | |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 48.46 per share. | 11 Jan 2022 | 4,883 | 156,385 (0%) | 0% | 48.5 | 236,630 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 49.15 per share. | 11 Jan 2022 | 536 | 155,849 (0%) | 0% | 49.1 | 26,344 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 46.37 per share. | 10 Jan 2022 | 7,095 | 161,911 (0%) | 0% | 46.4 | 328,995 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 47.15 per share. | 10 Jan 2022 | 643 | 161,268 (0%) | 0% | 47.1 | 30,317 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 03 Jan 2022 | 50,000 | 219,006 (0%) | 0% | 6.6 | 327,500 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 50,000 | 66,643 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 59.86 per share. | 03 Jan 2022 | 27,812 | 169,867 (0%) | 0% | 59.9 | 1,664,826 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 58.84 per share. | 03 Jan 2022 | 16,900 | 197,679 (0%) | 0% | 58.8 | 994,396 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 57.76 per share. | 03 Jan 2022 | 4,427 | 214,579 (0%) | 0% | 57.8 | 255,704 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 60.31 per share. | 03 Jan 2022 | 861 | 169,006 (0%) | 0% | 60.3 | 51,927 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 60,958 | 169,006 (0%) | 0% | 0 | Common Stock | |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 01 Oct 2021 | 50,000 | 158,048 (0%) | 0% | 6.6 | 327,500 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 50,000 | 116,643 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 58.96 per share. | 01 Oct 2021 | 21,844 | 119,892 (0%) | 0% | 59.0 | 1,287,966 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 58.03 per share. | 01 Oct 2021 | 16,312 | 141,736 (0%) | 0% | 58.0 | 946,634 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 59.68 per share. | 01 Oct 2021 | 11,844 | 108,048 (0%) | 0% | 59.7 | 706,862 | Common Stock |